Mask Aids Therapy for Respiratory and Sleep Apnea

A new mask works with continuous positive airway pressure (CPAP) to treat patients with respiratory insufficiency or sleep apnea. It is specially designed to promote therapy compliance by users. Called Nasal Aire, the new interface has been cleared by the US Food and Drug Administration (FDA).

Use of the Nasal Aire on patients in the early stage of respiratory distress may allow many to avoid the need to be intubated and placed on a ventilator. The mask requires no headgear, eliminates pressure points on the face and bridge of nose, contains no parts that can break from the device, and is worn like an oxygen cannula, says the developer, Innomed Technologies, Inc. (Boca Raton, FL, USA). The company notes that a very large percentage of patients give up their CPAP therapy because of problems relating to the masks and head gear. Studies have shown that when given a choice between using the Nasal Aire or one of the three leading competitive masks, 98% of patients chose Nasal Aire.

"We believe this device has the potential to revolutionize the sleep apnea market because it addresses so many of the primary issues concerning compliance,” said Russell Bird, president of Medical Industries of America, Inc.



Related Links:
Innomed